Tryptamine-Based SHIP Inhibitors for the Treatment of Cancer and Other Disorders

John Chisholm (Inventor), Sandra Fernandes (Inventor), William Kerr (Inventor)

Research output: Patent


The present disclosure provides compositions that inhibit the SH2-containing inositol 5′-phosphatase (SHIP), as well as methods using such compositions for use in treating or ameliorating the effects of a medical condition in a subject.
Original languageEnglish (US)
StatePublished - Jul 6 2017


Cite this